Loading...
 
Toggle Health Problems and D

Bone density improved by monthly 50,000 IU of vitamin D for 6 months – RCT Jan 2021

Effect of vitamin D therapy on bone mineral density in patients with diabetic nephropathy; a randomized, double-blind placebo controlled clinical trial

Journal of Diabetes & Metabolic Disorders (2021) https://doi.org/10.1007/s40200-021-00737-y
Gayani Liyanage, Sarath Lekamwasam, Thilak Weerarathna & Chandrani Liyanage

VitaminDWiki

Each of the following have been found to increase bone mineral density

  1. Enough of a good form of vitamin D for 6+ months (this study)
  2. Additonal vitamins and minerals which help grow bones (Magnesium, Calcium,silicon, etc)
  3. Stress on bones(exercise) to tell the body to increase the bone strength

Note: Bone strength is a much better indicator of Bone Mineral Density, but is rarely available

Poor guts need different forms of vitamin D

Guesses of Vitamin D response if poor gut

Bio FormSpeedDuration
10Injection ($$$)
or Calcidiol or Calcitriol
D - Slow
C -Fast
Long
10 Sun/UVBSlowLong
10Topical
(skin patch/cream, vagina)
Slow
Fast nano
Normal
9Nanoemulsion -mucosal
perhaps activates VDR
FastNormal
9?Inhaled (future)FastNormal
8Bio-D-Mulsion ForteNormalNormal
6Water soluble (Bio-Tech)NormalNormal
4Sublingual/spray
(some goes into gut)
FastNormal
3Coconut oil basedSlowNormal
2Food (salmon etc.)SlowNormal
2Olive oil based (majority)SlowNormal

10= best bioavailable, 0 = worst, guesses have a range of +-2
Speed: Fast ~2-6 hours, Slow ~10-30 hours
Duration: Long ~3-6 months, Normal = ~2 months

Falls and Fractures category contains the following

Hip fracture

Injection category listing has 58 items


Bone - Health category starts with the following

282 items in Bone - Health category
See also


Purpose
Diabetes compromises bone strength resulting increased risk of osteoporosis. Objective of this study was to determine the effect of vitamin D given to patients with early diabetic renal disease on BMD and BMC.

Methods
Patients with diabetic nephropathy were recruited. Treatment group received 50,000 IU of vitamin D3 intramuscularly and the control group was given an equal volume of distilled water (0.25 mL) monthly for six months. Baseline BMD, BMC in the total body, lumbar spine and proximal femur were measured by DXA. After six months measurements were repeated. When trial period was over, a randomly selected subgroup of patients (25 from each group) was followed up for further six-months and measurements were repeated.

Results
Selected patients were randomly assigned to two groups. After six months, the treatment group total body BMD, total body BMC and BMDs of spine, femoral neck and total hip regions increased by 2.0%, 2.2%, 1.8%, 2.1% and 2.6% (P < 0.05 for all within-group differences), respectively. In the Control group, BMD or BMC of any region mentioned above did not change significantly during the initial 6 months (P < 0.05 for the between-groups differences). After 6 months of stopping treatment, a statistically significant reduction of total BMD and BMC was observed in the treatment group (P = 0.009).

Conclusion
This study showed that treatment with high dose vitamin D significantly influences total body BMC, total body BMD, BMDs of spine, femoral neck and hip among patients with diabetic nephropathy.


Created by admin. Last Modification: Tuesday January 19, 2021 23:09:16 GMT-0000 by admin. (Version 7)
See any problem with this page? Report it (FINALLY WORKS)